volumes by 57-45%, depending upon the treatment regi men. These studies suggest that polyamine metabolism plays a role in the development of cerebral infarction after focal ischemia and that DFMO may be useful in limiting injury after a stroke. Key Words: Cerebral ischemia-u Difluoromethylornithine-Ornithine decarboxylase Polyamines- Reperfusion-Stroke. 1988 , 1992 . Induction of ODC and accumulation of putrescine are hypothesized to be responsible for the development of vasogenic edema and neuronal death (Koenig et aI., 1983; Trout et aI., 1986; Pas chen et aI., 1987 Pas chen et aI., , 1988 Dempsey et aI., 1988a Dempsey et aI., ,b, 1991 .
Delayed induction of ODC following ischemia reperfusion provides a window for pharmacological intervention. A rational therapeutic agent is a-di fluoromethylornithine (DFMO), an irreversible in hibitor of ODC (Metcalf et aI., 1978) . DFMO has been shown to preserve somatosensory evoked po tentials in postischemic brain (Dempsey et aI., 1988a) and to increase abdominal skin flap survival (Perona et aI., 1990) .
Information on polyamine metabolism in focal ce rebral ischemia is limited (Dempsey et aI., 1985; Paschen et aI., 199 1, 1992) . Increases in ODC after ischemia induced by middle cerebral artery occlu sion in the cat and rat have been reported (D empsey et aI., 1985; Paschen et aI., 1991) .
We examined the effects of reversible focal cere bral ischemia on ODC activity in the parietal cortex of the rat and determined the effects of DFMO on infarct size and on ischemia-induced changes in ODC.
MATERIALS AND METHODS

General preparation
Adult, male, pigmented Long-Evans rats (250-450 g; Harlan Sprague Dawley, Indianapolis, IN, U.S.A.) were used. Experimental procedures followed the NIH Guide for the Care and Use of Laboratory Animals. Ketamine (100 mg/kg i.p.)/xylazine (2.2-5.0 mg/kg i.m.) anesthesia was employed. Infarct volumes were assessed in the fol lowing:
Group 1. Preischemic DFMO regimen: DFMO (500 mg/ kg s.c., twice per day, n = 10) or vehicle (n = 10) for 3 days and again immediately prior to ischemia. Group 2. Ischemia-reperfusion DFMO regimen:
DFMO (500 mg/kg s.c., n = 10) or vehicle (n = 10) prior to and again 12 h following the onset of ischemia.
Group 3. Untreated (n = 5): ischemic insult without DFMO or vehicle. Group 4. Sham-operated (n = 5): isolation of common carotid and right middle cerebral arteries; no ischemia and no treatment.
Temporary occlusion of right middle cerebral artery
Temporary ischemia in the distribution of the right mid dle cerebral artery was produced as previously described (Chen et aI., 1986) . The right middle cerebral artery and both common carotid arteries were occluded for 60 min. Arterial blood gases, mean arterial pressures, and tempo ralis muscle and rectal temperatures were monitored prior to ischemia and shortly after the onset of reperfu sion. Temporalis muscle temperatures were measured un til closure of surgical wounds. Rectal temperatures were monitored prior to and throughout the entire period of ischemia and during reperfusion. Normothermia (37-38°C) was maintained until recovery from anesthesia.
Measurement of infarct volume
Twenty-four hours after ischemia, rats were deeply anesthetized, the left ventricle was perfused with saline, and the brain was placed briefly in cold saline, then sec tioned. Coronal slices were incubated in phosphate buffered saline (pH 7.4) containing 2% 2,3, 5-triphe nyltetrazolium chloride at 3rC (10 min) and then stored in 10% neutral-buffered formalin before measurement of infarct volume. Infarcts were confined to the ipsilateral cerebral cortex and were visualized as an area of un stained tissue in contrast to viable tissue, which stained red. Total infarct volume was expressed in cubic millime ters.
Determination of parietal cortical ODe activity
Rats treated with DFMO or vehicle (Group 2: isch emia-reperfusion regimen, n = 5-6) were killed at recir culation times of 2, 4, 8, 12, and 24 h. Sham-operated rats (n = 2-3) were killed at identical recirculation times.
Basal ODC activity was determined in the parietal cortex of uno per at ed, untreated rats (n = 12). Tissues from isch emic (right) and nonischemic (left) parietal cortices were collected and homogenized in 150 ILl of 50 mM N-2hydroxyethyl-l-piperazine-NI-2-ethanesulfonic acid (pH 7.2) containing 2 mM dithioerythritol and 60 ILM pyri doxal phosphate. The postmitochondrial supernatant was analyzed for ODC activity as described by Henley et al. (1987) . ODC activity was defined as decarboxylation of ornithine (pmol of CO2/30 min/mg protein) sensitive to inhibition by 500 ILM DFMO. Protein was determined J Cereb Blood Flow Metab, Vol. 13, No.6, 1993 using the Biorad assay (Biorad Labs, Richmond, CA, U.S.A.).
Statistical analysis
Values are presented as means ± SD. Analysis of vari ance was used to test for differences in the physiological variables and infarct volumes with an a-level set a priori at 0.05. Fisher's protected least-squares difference and the Scheffe F test were used to test for individual group differences (0. = 0.05).
RESULTS
Physiological variables
Blood glucose, arterial blood gases, blood pres sure, and rectal and ipsilateral temporalis muscle temperatures were measured prior to and during ischemia. Rectal and ipsilateral temporalis muscle temperatures were measured during the immediate period of reperfusion until surgical wounds were closed. Rats were then placed on heating pads and rectal temperatures were monitored until recovery from anesthesia. DFMO had no effect on any of these variables.
Infarct volumes
Untreated rats (Group 3), subjected to middle ce rebral artery occlusion and killed 24 h later, dem onstrated well-demarcated lesions confined to the ipsilateral parietal cortex, averaging 157 ± 46 mm3. No infarcts were visualized in the contralateral pa rietal cortex. Sham-operated rats (Group 4) pre sented no infarcts.
DFMO had a significant treatment effect on in farct volumes in both dosing regimens (Groups 1 and 2). Preischemic administration of DFMO (twice per day for 3 days and prior to ischemia) signifi cantly reduced infarct volumes to 42.6% of those observed in vehicle-treated animals, from 160 ± 51 to 72 ± 53 mm3• When DFMO was given immedi ately prior to ischemia and again 12 h later (isch emia-reperfusion regimen), infarct volumes were significantly reduced to 54.8% of those found in ve hicle-treated rats, from 186 ± 31 to 102 ± 48 mm3. Although mean infarct volumes tended to be some what less in the preischemic group, there was not a significant difference between the overall effect of preischemic and ischemia-reperfusion treatment.
ODe activity
ODe activity in the parietal cortex of control (un treated, unoperated) rats was 11.1 ± 10. 1 pmol eOi 30 min/mg protein. ODe activity in the cortex ipsi lateral to the site of the sham operation was signif icantly increased at 2, 4, 8, and 12 h after surgery compared with low basal ODe activity in unoper ated controls (Fig. lA) . In contrast, when compared with controls, there was no relative increase in ODe activity in the cortex contralateral to the sham-operated site (Fig. lB) .
In the ischemic parietal cortex of the vehicle treated rats, ODe activity changed significantly during reperfusion (Fig. lA) . After 2 h, the ODe activity gradually increased, peaking to 17.7 times the control values at 12 h and then returning to near control levels by 24 h. Ornithine concentrations in infarcted versus noninfarcted tissues were not high enough to alter the specific activity of the e4e]or- nithine used in the ODe assays. There was a small increase in ODe activity in the contralateral non ischemic parietal cortex (Fig. lB) of vehicle-treated animals between 2 and 12 h, but values were not significantly different from controls. DFMO effec tively blocked the ischemia-induced rise in ODe activity in both the ischemic and the nonischemic parietal cortices (Fig. 1) .
DISCUSSION
We studied the potential role of the ODe poly amine system in determining the severity of cere bral infarction after transient middle cerebral artery occlusion by quantifying ischemia-induced changes in ODe and the effects of DFMO on infarct size. ODe activity was significantly increased in isch emic parietal regions. Furthermore, DFMO blocked the ischemia-evoked increase in ODe and de creased the size of the cerebral infarction.
Staining with 2,3,5-triphenyltetrazolium chloride to quantify infarct volumes has shown good corre lation between the unstained tissue volumes and histological quantitation of infarct size at 24 h after ischemia (Bederson et aI., 1986; Isayama et aI., 1991) . However, volume measurements of infarcts may be overestimated by -22% because of edema (Brint et aI., 1988) . In the present study, it is un likely that the DFMO effect on infarct volumes was the sole result of edema reduction; however, edema reduction may have contributed in part to the dif ferences in infarct volumes. The infarct volume measured by the 2,3,5-triphenyltetrazolium chlo ride method does not change after 24 h in untreated animals (Bederson et aI., 1986; Isayama et aI., 1991) ; however, since later times were not exam ined in the present study, we cannot exclude the possibility that DFMO delayed rather than pre vented damage.
Reduction in infarct volume with DFMO may be a result of systemic effects or alterations in cerebral blood flow, rather than inhibition of cerebral ODe activity. However, this is unlikely since the physi ological variables monitored were not significantly different in vehicle and DFMO groups. In addition, both preischemic and ischemia-reperfusion dosing regimens were effective in reducing infarct volume, and inhibition of the ischemia-induced rise in corti cal ODe activity was demonstrated with DFMO (Group 2 protocol: ischemia-reperfusion regimen), suggesting a specific brain effect of the drug.
The mechanism of cerebral injury from activation of ODe is not completely understood. Disturbances in polyamine homeostasis including activation of the polyamine interconversion and catabolic path-ways, inhibition of spermidine and spermine syn thesis, and accumulation of putrescine may all be responsible for cell death. Putrescine accumulates in ischemic tissues and may mediate endothelial cell breakdown and vasogenic edema (Trout et al., 1986; Paschen et aI., 1987 Paschen et aI., , 1988 Dempsey et aI., 1988a) . A combination of acetylation and oxidation reactions participate in the intracellular conversion of polyamines (Seiler, 1988) . A product of the oxi dation reactions is hydrogen peroxide, which may participate in mechanisms of programmed cell death (Coffino and Poznanski, 1991) . Excessive re lease of polyamines into the extracellular space and interactions with serum oxidases following endo thelial cell breakdown are a likely scenario for pro duction of toxic metabolites responsible for the spread of neurotoxicity to adjacent neurons. In ad dition, extracellular polyamines may interact with specific polyamine binding sites at the N-methyl-D aspartate type of glutamate receptor (Williams et aI., 1991) to augment the intracellular flood of cal cium (Bondy and Walker, 1986) . DFMO can block N-methyl-D-aspartate-induced neurotoxicity in cul tured mouse cortical neurons (Markwell et aI., 1990) . This implies that induction of polyamine syn thesis occurs in concert with N-methyl-D-aspartate receptor activation to somehow contribute to the development of neuronal necrosis.
Because the activation of ODC peaks at 12 h after the period of temporary focal ischemia, therapeutic interventions to minimize this mechanism of injury may be feasible in the clinical situation of stroke. It is not known how long treatment with DFMO can be delayed after the ischemia and still be effective in reducing the injury, nor has the optimal dose of DFMO for this purpose been established. In addi tion, it is not known whether DFMO prevented the spread of ischemic damage or merely delayed the expression of damage. These issues, as well as the exact mechanism of the apparent protective effect, will be important questions for future studies.
